key: cord-0927842-c3ppw6qs authors: Davazdahemami, Behrooz; Zolbanin, Hamed M.; Delen, Dursun title: An explanatory analytics for early detection of chronic risk factors in pandemics date: 2022-01-10 journal: nan DOI: 10.1016/j.health.2022.100020 sha: 6fdf33f971c5fb386321e899fc5bc147c444dfe5 doc_id: 927842 cord_uid: c3ppw6qs Timely decision-making in national and global health emergencies such as pandemics is critically important from various aspects. Especially, early identification of risk factors of contagious viral diseases can lead to efficient management of limited healthcare resources and saving lives by prioritizing at-risk patients. In this study, we propose a hybrid artificial intelligence (AI) framework to identify major chronic risk factors of novel, contagious diseases as early as possible at the time of pandemics. The proposed framework combines evolutionary search algorithms with machine learning and the novel explanatory AI (XAI) methods to detect the most critical risk factors, use them to predict patients at high risk of mortality, and analyze the risk factors at the individual level for each high-risk patient. The proposed framework was validated using data from a repository of electronic health records of early COVID-19 patients in the US. A chronological analysis of the chronic risk factors identified using our proposed approach revealed that those factors could have been identified months before they were determined by clinical studies and/or announced by the United States health officials. Public health emergencies such as pandemics call for timely and efficient decision making and large-scale dissemination of resources [1] . Particularly, effective care for patients of a novel, contagious disease (especially if it has a potential for developing into an epidemic or a pandemic) depends highly on how much and when we know about the demographic and chronic risk factors of the disease. Such information not only can be used to identify the optimal treatment procedures for each individual regarding their characteristics and underlying medical conditions [2] , but also informs the high-risk population to follow the recommended health protocols. For this reason, since the onset of the recent COVID-19 pandemic, many clinical studies have attempted to identify the risk factors for severe disease and mortality among the patients. While these studies eventually provided an adequate understanding of the major risk factors for COVID-19, they are collectively inadequate for future pandemics for several reasons. First, most of the studies that were conducted in the early stages of the pandemic were, unsurprisingly, based on small samples of patients and left the complete identification of risk factors to later meta-analytic studies. Second, several studies focused on certain groups of patients (e.g., [3] - [5] ) rather than on diverse samples that represented the general population. Third, studies conducted to identify high-risk patients in the COVID-19 pandemic were mostly descriptive and did not provide a comparative assessment of the risk factors. Finally, these studies did not lead to the development of a comprehensive framework for future pandemics. This is crucial since it enables us to skip reinventing the wheel in a global health crisis and simply plug the data obtained from a consolidated sample of initial patients into a decision support system. J o u r n a l P r e -p r o o f Journal Pre-proof 3 This paper seeks to fill these gaps by using data from the early stages of the COVID-19 pandemic in the United States. Since the specification of 'early stages' is open to questions and arbitrary, we shift our focus from the timeline to the number of infected patients to determine how high-risk comorbidities can be identified as early as possible in an ongoing pandemic. While we focus our analyses on the data from the COVID-19 pandemic, the framework we propose is independent of the focal disease and works for any novel virus. In the following section, we review the existing literature on risk factors for severe illness or mortality among COVID-19 patients (later in the paper, we use this evaluation of prior work as a benchmark to validate our proposed framework). Next, regarding the lack of prior literature on a novel disease when a pandemic occurs, we employ descriptive analytics along with a prescriptive feature selection approach to determine the appropriate sample size and critical factors. Subsequently, we use the knowledge obtained from the descriptive analyses to build predictive models for high-risk patients and illustrate how each factor affects the odds of prognosis among the patients. We conclude the paper with a discussion of our contributions, limitations, and avenues for future research. Regarding the extent of the COVID-19 pandemic, a sizable number of studies have evaluated the risk factors for severe illness and death using data from inpatient hospital admissions. According to these studies, it is more likely for male [6] - [8] or older patients [8] - [9] to become severely ill or die from COVID-19. Among the chronic health conditions, obesity [10] - [12] , hypertension [8] , [13] , [14] , diabetes [8] , [14] , [15] , cardiovascular disease [14] , [16] , respiratory diseases J o u r n a l P r e -p r o o f Journal Pre-proof 4 such as COPD [8] , [14] , cerebrovascular illnesses [14] , cancer [8] , immunosuppression [17] , kidney diseases [18] , [19] , liver disease [20] , solid organ transplant [21] , and malnutrition [22] have been found by meta-analytic studies to increase the risk of severe illness or death among the patients. The Centers for Disease Control and Prevention (CDC) provides a more detailed list of COVID-19 risk factors; however, it does not identify the order of importance of these factors [5] . These conditions include cancer; chronic kidney disease; chronic lung diseases such as COPD, moderate-to-severe asthma, interstitial lung disease, cystic fibrosis, and pulmonary hypertension; neurological conditions such as dementia; type 1 or type 2 diabetes; down syndrome; heart conditions such as heart failure, coronary artery disease, or hypertension; weakened immune system; liver disease; obesity; hemoglobin blood disorders such as sickle cell disease or thalassemia; a history of smoking or substance abuse; solid organ or blood stem cell transplant; and cerebrovascular diseases. As expected, the CDC's list of risk factors conforms to the findings of the meta analytics studies. Inpatient and emergency department (ED) visits recorded in the Cerner HealthFacts data warehouse between December 31, 2019 (around the date China announced initial cases of the novel Coronavirus in Wuhan), and June 9, 2020, were used. The data were made available to the authors after being de-identified by Cerner to avoid any violation of patients' privacy. We excluded visits by non-adult (< 18 years of age) patients. All the 10,341 records (related to 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 10,189 unique patients) in the data set belonged to patients who were diagnosed with COVID-19 through at least one of the various diagnostic lab tests. In the next step of data processing, we used patients' historical health records to perform one-hot encoding for their chronic conditions (based on the ICD-10 coding system). We excluded acute conditions from our analyses because they could be a consequence of COVID-19 rather than a cause for an elevated risk among the patients. This resulted in 1,047 binary variables, where each variable denoted the existence of a chronic comorbidity in a patient. In addition to the diagnosis codes, patients' demographics and visit-specific information (i.e., age, gender, race, admission type, and payer type) were included for further analyses. Finally, we derived a binary response variable to indicate whether a patient survived or died from COVID-19. Based on our data set, 982 out of 10,189 (9.6%) patients died due to COVID-19. This rate is much higher than the average mortality rate (2-3%) reported for the disease [23] ; whereas this difference could partly be due to the fact that our data do not contain asymptomatic patients or those with mild symptoms who did not go to any healthcare facilities, yet it could also be partly attributed to the novelty of COVID-19, increased vulnerability of high-risk patients, and lack of resources to manage the disease in the early stages of the global outbreak. Table 1 summarizes the demographics of the final data set. Proportions of comorbidities among the two groups of patients (i.e., survived vs. died) are depicted in Figure 1 . Since our goal was to propose and evaluate a framework for the identification of risk factors at the beginning stages of pandemics, we assumed that the risk factors of COVID-19 are still unknown. As a result, we employed an exploratory approach to select the chronic comorbid conditions that affect the likelihood of an outcome in COVID-19 patients. Due to the large number of features, selecting a reasonably small set of most relevant factors that optimally predict death of patients was too computationally complex a problem to be solvable using the exact optimization methods. Hence, we employed Genetic Algorithm (GA) [24] -an evolutionary heuristic search approach -to come up with a decent nearly optimal solution. GA formulates each potential solution (i.e., feature set in our problem) as a chromosome-like string; it then generates a large number of chromosomes randomly (i.e., a population). Through several iterations (i.e., generations), chromosomes in each population are evaluated using a fitness function (i.e., prediction performance in this problem); then the top ones are kept for the next generation and the others are replaced by new chromosomes, partly generated randomly and partly generated by mating the top existing chromosomes (i.e., using crossover and mutation processes). The process of creating new generations continues until the changes in the fitness value of the best solution in a few consecutive generations is negligible (i.e., the algorithm converges). We used a forward feature selection GA, with a population size of 1,000 solutions in each iteration (i.e., generation) to refine the feature set. Each solution in the initial population included a random set of 50 conditions from the 1,407 features of the data set (i.e., around 3.5%). It should be noted that we ran the GA several times with different chromosome sizes (ranging from 30 to 200 features); however, for chromosome sizes above 50 features, the amount of 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 J o u r n a l P r e -p r o o f Journal Pre-proof 8 improvement in the fitness function was minimal. Thus, we chose 50 as the final size of the feature set. In each iteration, using the selected set of features for that iteration, we trained a basic random forest (RF) model with multiple chronological splits of data for training and validation. The reason we chose RF for feature selection was a large number of binary features in the data, which makes the data an excellent candidate for tree-based algorithms as compared to other machine learning techniques. We also tried other tree-based models, such as gradient boosted trees and a simple decision tree; however, RF yielded the best prediction results with the whole set of features in the model validation process. Table 2 shows the threshold dates used for splitting the data, as well as the proportion of training data associated with each threshold. Due to the slow rate of positive COVID-19 cases during January and February of 2020, we chose to go with jumps of two-week-long for the first few split thresholds but then decreased that to one week for the rest of the splits. A chronological split was critical since our goal was to identify the smallest number of patients (and therefore, the earliest possible time) for identifying a reliable set of risk factors. In each run, we used the area under the receiver operating characteristic curve (AUC) of the trained model as the fitness function to identify the top feature sets of that generation. We chose AUC as the fitness function because it specifies the power of each feature set in distinguishing the deceased from the survived patients. We defined a tournament selection strategy for the GA with a 20% survival rate, 30% elitism rate, 30% crossover rate, and 10% mutation rate. A maximum of 100 generations was set for the algorithm, with the possibility of an early stop if no improvements were observed in AUC in 10 consecutive generations. For each split setting, the group of features associated with the highest AUC was retained to be used for fine-tuning the prediction models in the next step. Since a majority of the predictors in our data were binary indicators of chronic comorbidities and given the high capability of tree-based models in handling categorical predictors, we selected RF to build the predictive models. Using the selected conditions for the split setting with the smallest training proportion (up to 01/31/2020), and by adding visit-and patient-related features, we finetuned the RF model hyperparameters to improve the predictive performance measures. To this end, we tried various split criteria (information gain, information gain ratio, and Gini index) for the decision trees and gradually increased the number of trees. An RF model with information gain ratio as the split criterion and 500 trees turned out as the winning configuration. We used this configuration to train the RF models for each of the data split settings (as pointed out in Table 2 ). We compared the predictive powers of the RF models trained on each of the first nine data split settings (see Table 2 ) against the predictive power of the last setting (which included the 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 highest training data proportion). The goal of this comparison was to determine the earliest split threshold that could yield a predictive model as good as the model that used around 80% of the data for training. Machine learning (ML) techniques are usually known as "black box" approaches with decent predictive power but little to no interpretability. In recent years, however, there has been a stream of research proposing various approaches, such as LIME [25] , DeepLIFT [26] , and Layer-Wise Relevance Propagation [27] , to improve the interpretability aspect of ML (See [28] , [29] for a comprehensive review of such methods). Similarly, Lundberg and Lee [30] propose 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 instance. Considering all marginal contributions of f across all possible coalitions of features, we may calculate a weighted average of those marginal contributions and attribute it to the feature f as its importance score (i.e., SHAP value) in predicting the outcome of that particular instance. In mathematical terms, the SHAP value of feature f for instance x is shown in Equation 1 [30] : where set represents any subset of features containing f, ( ) represents the predicted outcome for instance x using a model trained with the feature set s, |set| indicates the size of a feature set, and F represents the total number of features. In fact, the importance score for each feature represents the change in the expected model prediction when conditioning on that feature. Essentially, one major difference between SHAP and the classic Shapley values approach is the "local accuracy" property involved in SHAP, which enables it to explain every instance of a factor in the data by calculating a single marginal contribution for it; whereas Shapley values just assign an importance score to the whole factor (and not to each instance of data) [30] . As a result, using SHAP, we have an additive set of marginal contributions for each instance whose aggregation yields the prediction for that instance. Hence, in the specific context of this study, each patient's death probability (prediction) can be explained in terms of the additive marginal contributions of her corresponding health factors. Also, the overall importance score of each factor is simply the average of its marginal contributions across all instances (i.e., all patients). In the last stage of our proposed framework, and after developing a predictive model (stage 2) using the optimally selected features (stage 1), we employ SHAP to interpret the selected RF models (i.e., the earliest decent model identified at stage 2 along with the model trained with around 80% of data) and to identify the major chronic conditions that contribute to one's death/survival after contracting COVID-19. Figure 2 summarizes our proposed framework. 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 J o u r n a l P r e -p r o o f Journal Pre-proof 13 The GA models used for the different chronological splits were run on a computer with i9 2.90 GHz 8-Core processing power and 64GB memory. The models converged after between 23 and 29 generations, which took around 3-4 hours of processing in each case. The optimized feature set in each run involved 50 variables, each representing a chronic condition. We observed a 78% agreement rate across the different runs of the algorithm with different data splits. That is, 39 (out of 50) conditions were selected by the GA regardless of the data split settings. Also, the average best AUC across the different runs was 0.822 with a minimum of 0.814 and a maximum of 0.847. Table 3 contains a summary of the conditions commonly selected by all GA runs by their category (some conditions are common between multiple categories as they include complications). 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 In general, the categories of the risk factors identified in our study are the same as those found in meta-analytic studies; however, most of those studies were done several months after the beginning of the pandemic. Additionally, there are some conditions (categorized as "other") that are most common among senior adults (e.g., dementia, duodenal ulcer, arthritis, and cognitive impairment), denoting that their selection could be related to patients' age rather than the condition itself. This is in line with the point noted by MacLeod and Hunter [32] , who 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 suggest that the age-dependent effects of COVID-19 must be taken into account in the analyses of the disease data. We fine-tuned the RF model using the split configuration that included the smallest training portion (see Table 2 ) and used the same configuration to train the models with other split settings. Figure 3 shows the changes in overall accuracy, recall, specificity, and AUC by increasing the training portion of the data chronologically. For the first four split settings in Figure 3 , at least one of the four performance measures is relatively small. However, starting from the March 22 nd split (associated with 24.4% training proportion), the models become more stable and the changes in performance measures are negligible. In other words, considering a chronological split strategy, a model trained as early as 80 days after the official announcement of the emergence of the novel coronavirus (but less than 10 days after the lockdown in the US) turned out good enough to correctly predict around 87% of deaths (i.e., recall) and 73% of survivals, mainly based on the patients' demographics and chronic conditions. With coordinated global efforts and established processes for data sharing and analysis [33] , this period can potentially be shortened in future pandemics. While predicting survivability is a common application of data analytics in healthcare and involves various practical business implications [34] , [35] , understanding the risk factors associated with the outcome is of even higher importance, especially for novel diseases. Therefore, in the last step, we employed the SHAP algorithm to look into the most relevant risk factors among the selected features. First, we ran the algorithm for the last prediction model (involving 79.5% training data). Figure 4 (the blue bars) indicates the average SHAP scores for the top 20 features. We also ran the SHAP algorithm once more for the model trained with 24.4% of the data (i.e., March 22 split) to compare the score patterns. The patterned orange bars in Figure 4 indicate the average SHAP scores obtained from that run. 18 A closer investigation of the two sets of bars shows several similarities: seven out of the top ten chronic risk factors are common between the two models. A relatively high rank-order correlation (i.e., 0.87) between the risk factor scores suggests that a majority of the insights obtainable from the April 2020 model could have been obtained a month earlier in March 2020. This is particularly important given that the US experienced its first major hike in COVID-19 cases in April with a 385% monthly increase [36] in the number of patients. Expectedly, patients' age turned out as the top risk factor in both models. This risk factor is also identified by a large number of prior studies [37] - [40] as older people tend to have weaker immune systems. In addition, Race, Ethnicity, and Gender emerged as highly influential factors in both models. While there is little, if any, scientific evidence supporting the idea that some racial groups are more vulnerable to the COVID-19 infection, in line with Röösli et al. [41] we argue that the effect of race on the outcome in our models might be related to the socio-economic gaps in the US, as well as disparities in access to the required information and medical amenities in areas populated with minority racial groups. Unlike race and ethnicity, however, several prior studies on the risk factors of COVID-19 point to the greater vulnerability of men [6] , [40] , [42] . It should be noted that almost all the studies cited to validate our findings were published after March 2020. This means that the existence and application of the proposed framework in this study could have led to the identification of such risk factors weeks or months earlier than when they were noted in most scientific studies. Additionally, the number of historical diagnoses, as well as the number of diagnoses at the time of admission for each patient (both representing the general health of the patient), are among the top risk factors. In terms of chronic risk factors, a history of the diseases of the circulatory system (ICD-10 code Z86.7) is identified as the top risk factor in both models. Also, blood disorders such as 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 Thrombocytopenia and Lymphocytopenia have come out as the top risk factors among the COVID-19 patients in both models. A meta-analytic study performed by Lippi et al. [43] confirms that Thrombocytopenia is associated with more severe infections in COVID-19 patients. In addition, multiple studies mention Lymphocytopenia as a serious predictor of death in these patients [44] - [46] . Overall, in line with the findings of many studies published from mid-2020 to early 2021 (as shown in Table 1 ), our results suggest that chronic diseases of the circulatory systems, diabetes, kidney diseases, and chronic blood disorders are the major risk factors of COVID-19. A summary of the average SHAP scores for the major chronic conditions is shown in Table 4 . 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 In addition to providing a high-level picture of the major risk factors and their relative importance, the SHAP algorithm offers individual-level analyses of the features and their contribution to the probability of an outcome for each patient. Such analyses could be particularly helpful for medical practitioners in making the best decision for each patient given their underlying conditions. Figure 5, Our results show that a majority of the chronic risk factors of COVID-19 could have been identified as early as mid-March 2020, around the time that WHO officially announced the disease as a global pandemic and much earlier than when those risk factors were recognized by peer-reviewed studies. Given the results of this study, as well as other studies that focus on the potential time savings obtainable by employing data mining methodologies (e.g., [33] on early symptom detection), we believe that the national and international health agencies should coordinate their efforts and build the required infrastructure and capabilities to conduct data analytical investigations as early as possible in future large-scale health crises. Although the risk factors identified by our proposed approach were previously recognized in the literature, what makes the present study stand out is the ability of the proposed framework to obtain the same results in a much shorter time. This period can be shortened even further if international organizations that are responsible for global health policies establish effective surveillance and data governance policies for future pandemics [33] . For instance, while we used data from the early US cases (until March 22, 2020) to reliably determine the risk factors of COVID-19, the same results could have been obtained earlier if there was an infrastructure that enabled data sharing between countries. We argue that the earlier identification of risk factors would have led to reduced overall mortality in two major ways. First, more accurate information could have been communicated to high-risk patients earlier in the pandemic. Second, limited care resources could have been prioritized and administered more efficiently for better outcomes. As we pointed out earlier, a limitation of this study is the use of data from a single electronic health records (EHR) repository (i.e., not all the patients in the US). However, we believe that applying our proposed approach can save more time (and many lives) in pandemics, given the amount of data that are available to major national and international healthcare agencies. We encourage researchers who have access to multiple EHR sources to employ and validate our proposed framework, and to obtain a better estimate of the time or proportion of patients that are needed to identify risk factors of novel diseases reliably. While our results suggest 'age' as the top risk factor, looking into the chronic risk factors for each particular age group (e.g., 18-30, 30-45, etc. ) and comparing the similarities and differences could be even more insightful. Unfortunately, the data set used in this study was too limited in terms of the number of positive instances (i.e., patients died from COVID-19) in the younger age groups to let us train separate predictive and explanatory models. Future research may adopt our proposed framework by employing a larger data set of COVID-19 patients to address that interesting research question. Additionally, using COVID-19 data from other sources to replicate this study could help validating our findings and make them (fully or partially) more reliable for practical decision 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 10.1111/ijlh.13351. [46] J. Liu et al., "Lymphopenia predicted illness severity and recovery in patients with COVID-19: A single-center, retrospective study," PLoS One, vol. 15, no. 11, p. e0241659, Nov. 2020 . 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 Modeling and optimizing the public-health infrastructure for emergency response Clinical characteristics of 25 death cases with COVID-19: a retrospective review of medical records in a single medical center HIV infection and COVID-19: risk factors for severe disease Prevalence of COVID-19 Risk Factors and Risks of Severe Acute Respiratory Disease are Markedly Higher in Patients with Symptomatic Peripheral Arterial Occlusive Disease COVID-19 Risk Factors for Cancer Patients: A First Report with Comparator Data from COVID-19 Negative Cancer Patients Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission Systematic review and meta-analysis of sex-specific COVID-19 clinical outcomes Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies The age-related risk of severe outcomes due to COVID-19 Infection: a rapid review, meta-analysis, and meta-regression Obesity is a risk factor for developing critical condition in COVID-19 patients: a systematic review and meta-analysis Higher body mass index is an important risk factor in COVID-19 patients: a systematic review and meta-analysis Obesity and mortality of COVID-19. Meta-analysis Hypertension is a clinically important risk factor for critical illness and mortality in COVID-19: A meta-analysis Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: a meta-analysis of observational studies Prevalence of underlying diseases in died cases of COVID-19: A systematic review and meta-analysis Immunosuppression as a risk factor for COVID-19: a meta-analysis Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection Mortality in chronic kidney disease patients with COVID-19: a systematic review and meta-analysis Prevalence and associated risk factors of mortality among COVID-19 patients: A meta-analysis COVID-19 in solid organ transplant recipients: A systematic review and metaanalysis of current literature Prevalence and outcomes of malnutrition among hospitalized COVID-19 patients: A systematic review and metaanalysis Johns Hopkins Coronavirus Resource Center Genetic algorithms Explaining the predictions of any classifier Learning important features through propagating activation differences On pixel-wise explanations for non-linear classifier decisions by layer-wise relevance propagation Machine learning interpretability: A survey on methods and metrics Explaining Explanations: An Overview of Interpretability of Machine Learning A unified approach to interpreting model predictions Stochastic games The Impact of Age Demographics on Interpreting and Applying Population-Wide Infection Fatality Rates for COVID-19 Miscommunication in the age of communication: A crowdsourcing framework for symptom surveillance at the time of pandemics Automated model versus treating physician for predicting survival time of patients with metastatic cancer Predicting overall survivability in comorbidity of cancers: A data mining approach Infection fatality risk for SARS-CoV-2: a nationwide seroepidemiological study in the non-institutionalized population of Spain Age-specific mortality and immunity patterns of SARS-CoV-2 infection in 45 countries Adjusting COVID-19 Reports for Countries' Age Disparities: A Comparative Framework for Reporting Performances COVID-19 mortality risk for older men and women Bias at warp speed: how AI may contribute to the disparities gap in the time of COVID-19 Sex differential in COVID-19 mortality varies markedly by age Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis Lymphopenia in critically ill COVID-19 patients: A predictor factor of severity and mortality